Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit H1 Operative EBITDA Turns To Profit Of EUR 1.7 MLN

Aug 10 (Reuters) - Biohit Oyj  BIOBV.HE :
    * BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2022
    * H1 REVENUE EUR 6.1 MILLION (EUR 4.0 MILLION)
    * H1 OPERATIVE EBITDA EUR 1.7 MILLION VERSUS LOSS EUR 0.2
MILLION
YEAR AGO
    * EXPECTS ITS EBIT TO BE POSITIVE IN 2022 (2021: -1.5
MILLION
EUROS)
    * MAIN RISKS ARE LINKED TO WEAKENING GLOBAL ECONOMIC OUTLOOK
AND
RISING INFLATION THAT IS A THREAT TO COST COMPETITIVENESS.

Source text for Eikon:  ID:nWkr584YbV 
Further company coverage:  BIOBV.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Biohit Oyj

See all news